Gene: AASS
Official Full Name: aminoadipate-semialdehyde synthaseprovided by HGNC
Gene Summary: This gene encodes a bifunctional enzyme that catalyzes the first two steps in the mammalian lysine degradation pathway. The N-terminal and the C-terminal portions of this enzyme contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde. Mutations in this gene are associated with familial hyperlysinemia. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32210 | AASS Knockout cell line (HeLa) | Human | AASS | 1:3~1:6 | Negative | Online Inquiry |
KO32211 | AASS Knockout cell line (HCT 116) | Human | AASS | 1:2~1:4 | Negative | Online Inquiry |
KO32212 | AASS Knockout cell line (HEK293) | Human | AASS | 1:3~1:6 | Negative | Online Inquiry |
AASS Gene Knockout Cell Lines are specialized cell models in which the AASS gene (which encodes the enzyme aminoadipate-semialdehyde synthase) has been intentionally disrupted. This knockout technique involves the use of CRISPR-Cas9 or other gene-editing strategies, enabling researchers to analyze the phenotypic consequences and biochemical pathways influenced by the AASS gene. The main function of these cell lines is to provide a platform for studying metabolic disorders, particularly those associated with lysine metabolism and the potential development of therapeutic approaches for related pathologies.
The mechanisms underlying the utility of AASS Gene Knockout Cell Lines are rooted in their ability to facilitate targeted investigations into the consequences of AASS deficiency. Researchers can examine alterations in metabolic pathways, conduct drug screening for potential corrective therapies, and assess the cellular response to environmental changes. This detailed analysis extends to the examination of phenotypic characteristics, which may reveal insights into cellular stress responses and apoptosis mechanisms linked to AASS-related diseases.
The scientific importance of these cell lines lies in their application across various research and clinical settings, including metabolic disease studies, cancer research, and therapeutic development. They serve as valuable tools for unraveling the complexities of amino acid metabolism and can assist in the identification of biomarkers for diseases relevant to AASS deficiency, such as non-ketotic hyperglycinemia.
Compared to traditional cell lines, AASS Gene Knockout Cell Lines offer specificity in studying gene function without the confounding effects of the gene's presence. Their unique selling points include precise gene editing, reproducibility in experimental results, and the potential to model diseases more accurately than non-gene-edited systems.
This product is essential for researchers seeking to deepen their understanding of genetic influences on metabolic health or those aiming to develop novel therapeutic strategies. With AASS Gene Knockout Cell Lines, users can push the boundaries of research, enabling discoveries that could lead to meaningful clinical advancements.
Our company is dedicated to providing high-quality biological products backed by expertise in genetic engineering, ensuring our customers access the best tools for their research and clinical applications. We continuously strive to support scientific advancement with innovative solutions that meet the needs of today's research environment.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.